DM Case Study
A 75% Reduction in Operational Costs to Filing Ahead of the Schedule: Decoding 60 Degrees Pharmaceutical’s Dream SEC Transformation With IRIS CARBON®
Innovative pharmaceutical company 60 Degrees Pharmaceuticals faced mounting challenges with SEC reporting as manual data consolidation, fragmented document ownership, and escalating EDGARization costs slowed filings and increased operational risk.
This case study shows how 60 Degrees Pharmaceuticals transformed its SEC reporting process by adopting a centralized, data-centric disclosure management approach with IRIS CARBON®.
Learn how 60 Degrees Pharmaceuticals:
- Consolidated SEC reporting into a single, connected source of truth.
- Eliminated manual copy-paste errors with smart data and narrative linking.
- Brought XBRL tagging and EDGARization in-house to significantly reduce third-party costs.
- Improved cross-functional collaboration with real-time visibility and version control.
- Filed its 10-Q two days ahead of schedule, that's an outcome that once felt impossible.
